Top Markets
Coin of the day
YanAn Bicon Pharmaceutical Listed Company YanAn Bicon Pharmaceutical Listed Company

YanAn Bicon Pharmaceutical Listed Company

002411
Rang in Aktien #20199
YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused... YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused on the entire lifecycle—from research and development to production and distribution—of pharmaceutical intermediates, pesticide intermediates, and advanced energy and materials products. Its product portfolio features medical goods sold under the "Bikangweizheng" and "DoctorBaby" brand names. The company's product offerings include lithium hexafluorophosphate, a key constituent for lithium-ion battery electrolytes. Beyond this, it manufactures and supplies various high-performance composite materials. These composite materials are integral to numerous applications, including but not limited to cut-resistant gloves, home textile items, cables, fishing nets, outdoor sportswear, bulletproof helmets, stab-resistant clothing, as well as components for military and aerospace industries, ocean-going vessels, naval ship ropes, deep-sea fishing trawls, anti-wind wave cages, sporting equipment, and construction engineering reinforcement. Among its pharmaceutical intermediates are triclopyridine sodium, 5,5-dimethylhydantoin, and benzaldehyde. Established in 2007 and headquartered in Xi'an, China, the company underwent a name change in October 2018. Previously known as JiangSu Bicon Pharmaceutical Listed Company, it adopted its current designation, YanAn Bicon Pharmaceutical Listed Company. It was formerly an affiliate of Xinyi Bicon New Medicine Industry Complex Investment Co., Ltd.
Aktienkurs
$0.08984661
Zuletzt synchronisiert: 2023-07-11
Marktkapitalisierung
$137.67M
Veränderung (1 Tag)
-5.84%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel YanAn Bicon Pharmaceutical Listed Company (002411)
Gewinn für YanAn Bicon Pharmaceutical Listed Company (002411)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von YanAn Bicon Pharmaceutical Listed Company betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von YanAn Bicon Pharmaceutical Listed Company von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten